G. Leemans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
G. Leemans has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
J. Gutermuth
Department of Dermatology Vrije Universiteit Brussel (VUB) Universitair Ziekenhuis Brussel (UZ Brussel) Brussels Belgium
2 shared publicationsM. Grosber
Department of Dermatology Vrije Universiteit Brussel (VUB) Universitair Ziekenhuis Brussel (UZ Brussel) Brussels Belgium
2 shared publicationsA. Jadoul
SKIN Research Group Vrije Universiteit Brussel (VUB) Brussels Belgium
1 shared publication- Andreas Wollenberg
Department of Dermatology and Allergy, University Hospital Augsburg, Augsburg, Germany
1 shared publication - Inge Kortekaas Krohn
Skin Immunology & Immune Tolerance (SKIN) Research Group Vrije Universiteit Brussel (VUB) Brussels Belgium
1 shared publication - Jan Gutermuth
Department of Dermatology, Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel
1 shared publication
Latest Publications
- 26 April 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (8) , E962-E964
Acute generalized exanthematous pustulosis in a patient with COVID‐19 infection
- 26 April 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (8) , E962-E964
Acute generalized exanthematous pustulosis in a patient with COVID‐19 infection
- 13 April 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (8) , E1006-E1008
JAK1/2 pathway‐specific treatment of disseminated granuloma annulare with baricitinib
- 13 April 2023
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 37 (8) , E1006-E1008
JAK1/2 pathway‐specific treatment of disseminated granuloma annulare with baricitinib
- 6 January 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (4) , 876-879
ERCC2 mutations in two siblings with a severe trichothiodystrophy phenotype
Background: Trichothiodystrophy (TTD) describes a group of rare genetic disorders of DNA repair, characterized by sulphur‐deficient hair, skin anomalies and systemic complications like preterm delivery, neurological impairment, haematological and ophthalmological abnormalities and life‐threatening infections.Objectives: The aim of this case report was to investigate the contribution of the gene mutation to the phenotype.Methods: We describe the clinical and molecular characteristics of a family with two TTD‐affected siblings who died before the age of 2 years.Results: The causal mutated gene is the ERCC2 gene, and one of the identified mutations is the c.2164C>T (p.Arg722Trp) variant. The association of this mutation with a severe TTD phenotype was suggested earlier in literature, and the present family adds further evidence to this hypothesis.Conclusion: Accurate identification of the underlying genetic defect can guide the clinical follow‐up and counselling of patients and their families.
- 6 January 2020
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 34 (4) , 876-879
ERCC2 mutations in two siblings with a severe trichothiodystrophy phenotype
Background: Trichothiodystrophy (TTD) describes a group of rare genetic disorders of DNA repair, characterized by sulphur‐deficient hair, skin anomalies and systemic complications like preterm delivery, neurological impairment, haematological and ophthalmological abnormalities and life‐threatening infections.Objectives: The aim of this case report was to investigate the contribution of the gene mutation to the phenotype.Methods: We describe the clinical and molecular characteristics of a family with two TTD‐affected siblings who died before the age of 2 years.Results: The causal mutated gene is the ERCC2 gene, and one of the identified mutations is the c.2164C>T (p.Arg722Trp) variant. The association of this mutation with a severe TTD phenotype was suggested earlier in literature, and the present family adds further evidence to this hypothesis.Conclusion: Accurate identification of the underlying genetic defect can guide the clinical follow‐up and counselling of patients and their families.